Institut de Recherches Internationales

Institut de Recherches Internationales Servier (IRIS) is the primary clinical research and development arm of the Servier Group, a leading international pharmaceutical company. IRIS is responsible for the global management of clinical trials, spanning from Phase 1 through Phase 4, ensuring that all research activities comply with international regulatory standards and Good Clinical Practice. The institute focuses on developing innovative therapies in key therapeutic areas including oncology, cardiovascular diseases, metabolic disorders, and neurosciences. By operating as an internal contract research organization, IRIS streamlines the transition of drug candidates from laboratory discovery to commercial availability. Its work is central to Servier's mission of providing therapeutic solutions for unmet medical needs worldwide.